Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride].
about
Role of solute carriers in response to anticancer drugsEvaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial dataPhase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.Contribution of tumoral and host solute carriers to clinical drug response.Overlapping functions of ABC transporters in topotecan disposition as determined in gene knockout mouse models.Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs).Renal Drug Transporters and Drug Interactions.Organic anion transporter OAT1 is involved in renal handling of citrulline.Usefulness of kidney slices for functional analysis of apical reabsorptive transporters.Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies.
P2860
Q27027625-28B42BCE-ABFC-4177-8F3D-1F283EF2B5D7Q33388617-A9572ECE-A7E7-4489-8220-9BA77CF8C14BQ33412801-C7C3BF22-B432-48D4-923A-DF52D694B54CQ35946876-563FC2DD-9CB4-4C1D-8E65-C2D4029CB502Q37001278-897D3453-F693-4756-97FF-FF20004F0641Q37311185-35F69CC8-7D34-4652-A986-2D55807F3637Q37558398-E7659EA8-6E3F-40E0-BF2C-440C8A49E89EQ38888345-B54782F7-6DFF-4EE4-A58A-3B6FF281BD6BQ38923106-A6BB00A0-C4E4-4F7F-BD17-E272CE5C83A1Q39140289-65F98C49-F74A-4189-B871-3ABADA453EC3Q39858796-75F12C19-4BF6-42D3-ADC9-A28B086F291EQ42373933-463BFBCD-C188-43EE-886A-64356D7A0AE2Q53529517-B98CDC9A-2744-48B1-BF00-3377BD56BA67
P2860
Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride].
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Involvement of rat and human o ...... bular secretion of topotecan [
@nl
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@ast
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@en
type
label
Involvement of rat and human o ...... bular secretion of topotecan [
@nl
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@ast
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@en
prefLabel
Involvement of rat and human o ...... bular secretion of topotecan [
@nl
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@ast
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@en
P2093
P356
P1476
Involvement of rat and human o ...... y-camptothecin hydrochloride].
@en
P2093
Ikumi Tamai
Kenji Yoshida
Naoki Ishiguro
Shin-ichi Matsumoto
Tomoji Maeda
P304
P356
10.1124/JPET.107.123323
P407
P577
2007-06-07T00:00:00Z